Lundbeck increased operating profit (EBIT) with 126% and EPS by 182% in the first nine months of 201

Discussion in 'Lundbeck' started by anonymous, Nov 17, 2017 at 12:46 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    You might find it interesting to see how much Lundbeck USA drives global profits now.

    http://quote.morningstar.com/stock-filing/Quarterly-Report/2017/9/30/t.aspx?t=:HLUYY&ft=&d=09a3ca1904ebe61714931fbc49fc991f


    Check out each brand's income levels for the year, q3 vs q3 2016

    if you are like most sales reps, you can see the game has been rigged a long time. Northera sure has made the company a mother load of money. 54% growth.... funny the country has been at 97-98% of goal nationally all year each trimester yet the "cash payout" has been a windfall.

    Then you see about charity investigations. The company has kept it quiet but it's in the annual report from February:

    In May 2016, Lundbeck NA Ltd (formerly known as Chelsea Therapeutics, Inc.) received a subpoena from the US Attorney’s Office in Boston, Massachusetts relating to an investigation of payments to charitable organizations providing financial assistance to patients taking Lundbeck products, and to Northera® and Xenazine® sales, marketing and related practices. Lundbeck LLC is cooperating with the relevant authorities on this investigation.

    Some drug companies are settling the cases to just get away from it. This all makes sense why our new direction is chasing commercial pay and not having any help any longer with foundations. The foundations all drug companies were aware of the laws being exempt and like any good deal.... greed and manipulation came around to rear its ugly head.

    With all the brands showing growth, it's hard to imagine we would have so many people quitting. After all we all should have been making record bonuses to coincide with the amazing sales numbers we have
     

  2. anonymous

    anonymous Guest

    and here it is...

    "In January 2016, Lundbeck LLC, USA received a subpoena from the US Attorney’s Office for the District of Rhode Island relating to an investigation of Xenazine® sales, marketing and related practices. Lundbeck LLC is cooperating with the relevant authorities on this investigation.

    In May 2016, Lundbeck NA Ltd (formerly known as Chelsea Therapeutics, Inc.) received a subpoena from the US Attorney’s Of ce in Boston, Massachusetts relating to an investigation of payments to charitable organizations providing nancial assistance to patients taking Lundbeck products, and to Northera® and Xenazine® sales, marketing and related practices. Lundbeck LLC is cooperating with the relevant authorities on this investigation."
     
  3. anonymous

    anonymous Guest

    Get a job and a life you lonely fuck face fired troll !
     
  4. anonymous

    anonymous Guest

    all these profits are going to settle with the US government, Kare was smart to get out of dodge
     
  5. anonymous

    anonymous Guest